Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA) reported earnings of $0.78 per share beating Walls Streets expectations.

ME Staff
-
0

Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA) reported 6/30/2018 earnings this Morning, coming in at $0.78 per share, beating Wall Street’s estimates of $0.64 per Share. Revenue for the quarter came in at $4.70 billion missing the streets estimates of $4.75 billion

Recent Insider Trading for Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA)

  • On 5/10/2018 Roberto Mignone, Director, bought 750,000 with an average share price of $19.24 per share and the total transaction amounting to $14,430,000.00.
  • On 3/19/2018 Deborah A Griffin, Insider, sold 943 with an average share price of $17.88 per share and the total transaction amounting to $16,860.84.
  • On 3/19/2018 Michael James Mcclellan, CFO, sold 287 with an average share price of $17.88 per share and the total transaction amounting to $5,131.56.
  • On 3/19/2018 Richard Daniell, VP, sold 1,297 with an average share price of $17.89 per share and the total transaction amounting to $23,203.33.
  • On 3/19/2018 Sven Dethlefs, EVP, sold 571 with an average share price of $17.88 per share and the total transaction amounting to $10,209.48.
  • On 3/5/2018 Brendan P O’grady, EVP, sold 705 with an average share price of $19.38 per share and the total transaction amounting to $13,662.90.



Dividend History for Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA)

  • On 11/2/2017 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.0850 2.74% with an ex dividend date of 11/27/2017 which will be payable on 11/28/2017.
  • On 8/7/2017 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.0850 1.83% with an ex dividend date of 8/25/2017 which will be payable on 8/29/2017.
  • On 5/11/2017 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.34 4.28% with an ex dividend date of 6/1/2017 which will be payable on 6/5/2017.
  • On 2/13/2017 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.34 3.7% with an ex dividend date of 2/28/2017 which will be payable on 3/2/2017.
  • On 11/15/2016 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.34 with an ex dividend date of 12/1/2016 which will be payable on 12/5/2016.
  • On 8/4/2016 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.34 with an ex dividend date of 8/18/2016 which will be payable on 8/22/2016.
  • On 5/9/2016 Teva Pharmaceutical Industries Ltd (ADR) ADR announced a quarterly dividend of $0.34 with an ex dividend date of 5/20/2016 which will be payable on 5/24/2016.



About Company
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

Recent Analyst Rating for Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA)

  • On 11/2/2017 quarterly, $0.0850, to 2.74% with a price target of 11/27/2017
  • On 11/28/2017 12/12/2017 8/7/2017, quarterly, to $0.0850 with a price target of 1.83%
  • On 8/25/2017 8/29/2017, 9/14/2017 5/11/2017, to quarterly with a price target of $0.34
  • On 6/1/2017 6/5/2017, 6/22/2017 2/13/2017, to quarterly with a price target of $0.34
  • On 2/28/2017 3/2/2017, 3/20/2017 11/15/2016, to quarterly with a price target of $0.34
  • On 12/1/2016 12/5/2016, 12/20/2016 8/4/2016, to quarterly with a price target of $0.34



Recent Trading for Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA)
Shares of Teva Pharmaceutical Industries Ltd (ADR) ADR closed the previous trading session at 21.61 −2.26 9.47% with 23.37 shares trading hands.